Search StockRing Blog

Tuesday, October 27, 2009

StockRing.com

Login    About Us    Our Blog    Our Twitter    Contact Us   
 10/27/09, (NYSE:JNJ), $60.08, "BUY" Johnson & Johnson (JNJ) Stock
 JNJ opened at $60.30 and it is $-0.01, (-0.02%). Today's trading range is $59.96 - 60.40. 1y target price is $64.57.

 DOW    +0.16%   +15.87   9883.83          ENGLAND    +0.18%   +9.23   5200.97          JAPAN    -1.45%   -150.16   10212.46
 NASDAQ    -1.13%   -24.26   2117.59          GERMANY    -0.13%   -7.14   5635.02          CHINA    -2.83%   -88.11   3021.459
 S&P 500    -0.29%   -3.13   1063.82          FRANCE    -0.01%   -0.5   3743.95          INDIA    -2.31%   -387.1   16353.40
 CANADA    -1.46%   -164.24   11070.64          ITALY    -1.09%   -174.00   15743.00          RUSSIA    -3.71%   -54.77   1421.29
 MEXICO    -2.53%   -765.04   29515.039          SWISS    +1.03%   +64.62   6367.97          TAIWAN    -0.14%   -11.06   7657.34
 
 

Stocks
Funds

SYMBOL:
  

YouTube
Our Blog




10/17/09 StockRing Urgent Advice: Sell stocks on 10/19/09 - expect pull back this week !!!
  
Option Exp: SAMPLE ! Option Exp:
Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!

1. Dow Jones Index - 30 Stocks on 10/26/2009:  Buy   77% or 23   Hold   16% or 5   Sell   7% or 2 stocks
2. Best Brands - 200 stocks on 10/26/2009:  Buy   66% or 132   Hold   13% or 26   Sell   21% or 41 stocks
3. Hot News - 200 stocks on 10/26/2009:  Buy   71% or 141   Hold   11% or 23   Sell   18% or 35 stocks
4. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341   Hold   21% or 106   Sell   11% or 53 stocks
5. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292   Hold   15% or 61   Sell   12% or 47 stocks
6. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   66% or 395   Hold   26% or 156   Sell   8% or 49 stocks
7. Nasdaq 100 Index - 100 Stocks on 7/21/2009:  Buy   75% or 75   Hold   17% or 17   Sell   8% or 8 stocks
8. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81   Hold   35% or 56   Sell   16% or 27 stocks
9. Nasdaq Biotech - 136 Stocks on 7/24/2009:  Buy   57% or 78   Hold   33% or 45   Sell   10% or 13 stocks
10. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263   Hold   26% or 115   Sell   14% or 62 stocks
11. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109   Hold   6% or 12   Sell   33% or 59 stocks
12. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58   Hold   34% or 34   Sell   8% or 8 stocks
13. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133   Hold   51% or 176   Sell   11% or 37 funds
14. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84   Hold   46% or 73   Sell   2% or 4 funds
15. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19   Hold   50% or 47   Sell   30% or 28 stocks
16. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111   Hold   34% or 70   Sell   13% or 28 stocks
    17. World Markets - 72 Indexes on 10/23/2009:  Buy   86% or 60   Hold   4% or 3   Sell   10% or 7 indexes
                                             TOTAL RATINGS:   Buy   79% or 2395   Hold   3% or 1025   Sell   18% or 508 stocks


Video: 6-24-09 - Dow 30 stocks Buy-Sell-Hold Ratings
10/27/2009  Tuesday, October 27, 2009 (Irvine, California) Today StockRing.com Recommendation is to "BUY"for Johnson & Johnson (NYSE:JNJ) Stock. JNJ stock opening price was $60.30 per share. Current price of NYSE:JNJ Stock is $60.08 per share and it is $-0.01, (-0.02%) today and it was trading in the daily range of $59.96 - 60.40 per share. Current Bid Price for (NYSE:JNJ) stock is $60.08 and the Ask Price is $60.09. In the last 52 weeks JNJ stock was trading in the range of $46.25 - 64.50. 50-Day Moving Average for (NYSE:JNJ) stock is $60.6831 and 200-Day Moving Average is $57.7574. On average analysts predict that One Year Target Estimated price for (NYSE:JNJ) stock is $64.57.

Johnson & Johnson (NYSE:JNJ) Market capitalization is $165.6B. (NYSE:JNJ) stock average daily volume is 10,522,300 shares per day. However, on last trading session of 1:37pm, 2009 JNJ stock traded 5,651,628 shares. Also The Short Ratio for (NYSE:JNJ) stock is 2.40. On previous trading session JNJ Stock closed at $60.09 per share.

Last year Johnson & Johnson (NYSE:JNJ) before taxes (EBITDA) (ttm) earned $19.055B on total revenue of $60.528B. Earnings Per Share - EPS (ttm) for JNJ stock is 4.579. Also, (NYSE:JNJ) Stock Price Per Earnings ratio - P/E is 13.12. Thus, (NYSE:JNJ) Stock Price/Sales (ttm) ratio is 2.74 and Price/Book (mrq) ratio is 3.58.

(NYSE:JNJ) Stock pays a dividend of $1.90 per share which is a yield of 3.16%. So at this time (NYSE:JNJ) Stock maintains Trailing Annual Dividend Rate at 1.90 .
StockRing Recommendations for Johnson & Johnson (NYSE:JNJ) Stock are updated daily here

http://www.StockRing.com/sr/StockDetail.asp?StockName=JNJ

If you would like to receive Buy-Sell-Hold ratings for over 50,000 stocks, mutual funds, and ETFs go to StockRing web site: http://www.StockRing.com.




JNJ Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max   News    Options!   More Info

10/27/2009 1 Year Stock market price chart for Johnson & Johnson (NYSE:JNJ) Stock on Tuesday, October 27, 2009
  
1 Year Dow Jones Chart 1 Year S&P 500 Chart
1 Year Nasdaq Chart 1 Year Canada Chart

10/27/2009 5 days Stock market price chart for Johnson & Johnson (NYSE:JNJ) Stock on Tuesday, October 27, 2009
  
5 Days Dow Jones Chart 5 Days S&P 500 Chart
5 Days Nasdaq Chart 5 Days Canada Chart


JNJ Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max   News    Options!
   More Info


10/27/2009 Stock market price quote data for Johnson & Johnson (NYSE:JNJ) Stock on Tuesday, October 27, 2009

Last Trade: 60.08
Trade Time: 1:37pm
Change: -0.01, (-0.02%)
Prev Close: 60.09
Open: 60.30
Bid: 60.08
Ask: 60.09
1y Target Est: $64.57
50-Day Moving Average: 60.6831
200-Day Moving Average:
57.7574
Short Ratio: 2.40
Trailing Annual Dividend Rate: 1.90
Day's Range: 59.96 - 60.40
52wk Range: 46.25 - 64.50
Volume: 5,651,628
Avg Vol: 10,522,300
Market Cap: 165.6B
P/E (ttm): 13.12
EPS (ttm): 4.579
Div & Yield: 1.90 (3.16%)
Revenue (ttm): 60.528B
Earnings before Tax (EBITDA) (ttm): 19.055B
Price/Sales (ttm): 2.74
Price/Book (mrq): 3.58


Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!
                 

1. Dow Jones Index - 30 Stocks on 10/26/2009:  Buy   77% or 23   Hold   16% or 5   Sell   7% or 2 stocks
2. Best Brands - 200 stocks on 10/26/2009:  Buy   66% or 132   Hold   13% or 26   Sell   21% or 41 stocks
3. Hot News - 200 stocks on 10/26/2009:  Buy   71% or 141   Hold   11% or 23   Sell   18% or 35 stocks
4. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341   Hold   21% or 106   Sell   11% or 53 stocks
5. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292   Hold   15% or 61   Sell   12% or 47 stocks
6. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   66% or 395   Hold   26% or 156   Sell   8% or 49 stocks
7. Nasdaq 100 Index - 100 Stocks on 7/21/2009:  Buy   75% or 75   Hold   17% or 17   Sell   8% or 8 stocks
8. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81   Hold   35% or 56   Sell   16% or 27 stocks
9. Nasdaq Biotech - 136 Stocks on 7/24/2009:  Buy   57% or 78   Hold   33% or 45   Sell   10% or 13 stocks
10. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263   Hold   26% or 115   Sell   14% or 62 stocks
11. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109   Hold   6% or 12   Sell   33% or 59 stocks
12. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58   Hold   34% or 34   Sell   8% or 8 stocks
13. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133   Hold   51% or 176   Sell   11% or 37 funds
14. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84   Hold   46% or 73   Sell   2% or 4 funds
15. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19   Hold   50% or 47   Sell   30% or 28 stocks
16. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111   Hold   34% or 70   Sell   13% or 28 stocks
    17. World Markets - 72 Indexes on 10/23/2009:  Buy   86% or 60   Hold   4% or 3   Sell   10% or 7 indexes
                                             TOTAL RATINGS:   Buy   79% or 2395   Hold   3% or 1025   Sell   18% or 508 stocks


10/27/2009 Latest stock market news data for Johnson & Johnson (NYSE:JNJ) Stock on Tuesday, October 27, 2009

SAFE-BioPharma Receives Safe Harbor Certification
Reuters - 49 minutes ago
FT. LEE, NJ--(Business Wire)-- SAFE-BioPharma Association has certified compliance with the US Department of Commerce and European Union Safe Harbor requirements for the protection of personal ...
American Jobs Disappear While The Stock Market Is Surging
istockAnalyst.com - 20 hours ago
Wall Street and Main Streets gap has never been wider. Yet investors are enjoying a vibrant market while the unemployed are enjoying long lines at their local unemployment office. To them the ...
Johnson & Johnson names new board member
Trading Markets - Oct 26, 2009
Oct 26, 2009 (Datamonitor via COMTEX) -- XRX -- Johnson & Johnson, a US-based healthcare company, has appointed Anne Mulcahy, chairman of Xerox, to its board of directors. Ms Mulcahy was both ...
J&J to seek agreements with rivals to share risk
Financial Times - Oct 25, 2009
By Andrew Jack Johnson & Johnson, the US healthcare group, will in future take more long-term minority stakes and forge alliances with rival pharmaceuticals companies in an effort to share the ...
J&J CEO's Lower-Risk Alternative to Acquisitions - Wall Street Journal
J&J wants deals with rivals to share risk - FT Mobile
Financier Worldwide
Earnings are solid for J&J
Optician Online - Oct 24, 2009
Johnson & Johnson has reported sales for the third quarter of 2009 down 5.3 per cent at $15.1bn. Sales in Europe fell less sharply at $4.01bn, a 4.8 per cent decrease on the same quarter a year ...
J&J To Put California Manufacturing Plant Up For Sale
EasyBourse.com - Oct 23, 2009
By Peter Loftus Of DOW JONES NEWSWIRES Health-care products maker Johnson & Johnson (JNJ) plans to sell a California manufacturing plant where it makes the Duragesic pain patch, a spokeswoman said ...
Vacaville's ALZA up for sale
TheReporter.com - Oct 23, 2009
By Richard Bammer Vacaville's ALZA Corp., a pharmaceutical and medical delivery systems firm, is being offered for sale by its parent company, Johnson & Johnson, a corporate spokeswoman confirmed ...
Kimberly-Clark high on Q3 data
BloggingStocks - Oct 22, 2009
Kimberly-Clark Corporation (NYSE: KMB), a consumer products entity whose colleagues include Procter & Gamble (NYSE: PG) and Johnson & Johnson (NYSE: JNJ), is up today on third-quarter results. At ...
Healthcare M&A Activitiy: Three Healthcare Small Caps Primed For Takeovers
istockAnalyst.com - Oct 22, 2009
by Louis Basenese , Small Cap & Special Situations Expert Thursday, October 22, 2009: Issue #1121 With the healthcare debate still raging in Washington, this should shock you… Healthcare mergers ...
Xerox Chairman Anne M. Mulcahy Appointed to Johnson & Johnson Board of Directors
Reuters - Oct 22, 2009
NEW BRUNSWICK, NJ, Oct. 22 /PRNewswire-FirstCall/ -- Anne M. Mulcahy, Chairman of Xerox Corporation (NYSE: XRX), today was appointed to the Board of Directors of Johnson & Johnson (NYSE: JNJ), the ...
Johnson & Johnson appoints Xerox chairman to board - The Associated Press
Xerox Chairman Mulcahy Adds Another Directorship, Joining J&J - NASDAQ
Minneapolis Star Tribune


BEFORE THE BELL: US Stk Futures Mixed After J&J Data
Wall Street Journal
Johnson & Johnson (JNJ) reported a slight rise in third-quarter profit and hikes its outlook for the year. The health giant's stock fell 1.9% in pre-market ...
J&J Declines After Sales Miss Analysts' EstimatesBloomberg
J&J reports moderately higher earningsMarketWatch
Two Johnsons Give A Peek, Fail To PleaseForbes
The Associated Press -SYS-CON Media (press release) -MarketWatch
all 909 news articles »

The S&P 500's Outsized Expectations
Forbes
Consumer staples and health care companies like Johnson & Johnson ( JNJ - news - people ) have less opportunity. Levkovich points to food and tobacco as ...


Why Now Is Not the Time to Sell
Motley Fool
Tom owns shares of Microsoft, Cisco, and Johnson & Johnson, but of no other companies mentioned in this article. Best Buy is a Motley Fool Stock Advisor ...

and more »

Compugen Reports Third Quarter 2009 Financial Results
Reuters
The net loss for the most recent quarter was $1.9 million (including a non-cash expense of $460000 related to stock based compensation), or $0.06 per share, ...


supergen, Inc. Q3 2009 Earnings Call Transcript
Seeking Alpha (blog)
Specifically, GSK purchased approximately 990000 shares of supergen common stock at $3.03 per share. Based on issued and outstanding stock of approximately ...

and more »

BBC News

Johnson & Johnson, Goldman Sachs, CIT in focus
MarketWatch
Goldman Sachs had been Whitney's only buy-rated stock. Johnson & Johnson posted third-quarter net income of $3.35 billion, or $1.20 a share, compared with ...
CIT Group, Pier 1, Johnson & Johnson big moversThe Associated Press
Pre-Market: Stock Futures Twisting Around Even - Wall Street May Try To Extend ...istockAnalyst.com (press release)
USD, J&J, Goldman Sachs, CSX, eBay – VialouxNational Post
Forbes -Wall Street Journal -Briefing.com
all 1,960 news articles »

Consider This Before You Buy Another Stock
msnbc.com
Berkshire Hathaway is also a Stock Advisor choice. Coca-Cola and Johnson & Johnson are Income Investor picks. The Motley Fool owns shares of Berkshire ...

and more »

4-Star Stocks Poised to Pop: Molina
Motley Fool
UnitedHealth is also a selection of Stock Advisor. AOB is a Motley Fool Hidden Gems choice, Johnson & Johnson is an Income Investor pick, and First Solar is ...

and more »

The Star-Ledger - NJ.com

Stocks drift lower after Johnson & Johnson report
The Associated Press
More than three stocks fell for every one that rose on the New York Stock Exchange, where volume came to 229 million shares. The Dow Jones industrial ...
STOCKS NEWS US-Wall St falters on J&J, banks; Intel beats StreetInteractive Investor
Stocks End Little ChangedFirst Coast News
US STOCKS-Wall St weighed down by J&J, bank stocksReuters India
eTaiwan News
all 124 news articles »

The Unlikeliest Dividend Play
msnbc.com
Procter & Gamble, Coke, and Johnson & Johnson are Income Investor recommendations. Hansen Natural is a Rule Breakers pick. American Express, Berkshire ...

and more »



10/27/2009 News from StockRing Blog about Johnson & Johnson (NYSE:JNJ) Stock on Tuesday, October 27, 2009

   Abele John   Abrams George    Abrams Jonathan   Ackermann Josef   ACUSHNET   A.I.G.   AIG   Albright Madeleine   AMAZON.COM   AMERITRADE   Andelman David   Andreessen Marc   Angwin Julia   Anthony Jim   APAX PARTNERS   ARCH VENTURE PARTNERS   ARONSSON GROUP   Ashworth Paul   AT&T   AVON BOOKS   Bair Sheila   BANK OF AMERICA   BARCLAYS   Barton Rich   Bassett Angela   BEAR STEARNS   Begich Mark   Bell Bryon   Bennett Tony   Berke Barry   Bernanke Ben   BET   BETSEY JOHNSON   Biaggi Mario   Bierut Michael   Biondi Frank   Blankfein Lloyd   Blinder Alan   Bock Jeff   BOEING   Boncompagni Tatiana   Bond Adam   Bond Victoria   Born Brooksley   BOSTON SCIENTIFIC   BP   Brazinski Daniel   Breslin Jimmy   Brody Kenneth   Brown Greg   Burkle Ron   Burow Kristina   Burrough Bryan   Bush George W.   Callan Erin   CALLAWAY GOLF   CARLYLE GROUP    CASCADE INVESTMENT   Cassano Joseph   Dauman Philippe   De Niro Robert   Dickerson Paul   Dillon Harrison   DISNEY   Dodd Christopher   Donaldson William   Douglas Michael   Draghi Mario   DREAMWORKS SKG   DUTTON   Dykstra Lenny   Eisner Michael   ELECTRONIC ARTS   Emanuel Rahm   ENRON   ESL INVESTMENTS   Evans Robert   Falcone Philip   FANNIE MAE   FEDERATED DEPARTMENT   STORES   FINANCO   Flavin Jennifer   Fleckenstein Bill   Foreman George   Frank Barney   Frears Stephen   FREDDIE MAC   Freston Tom   Friedman Stephen   Fuld Dick   Furman Roy   Garavani Valentino   Gates Bill   Geffen David   Geithner Tim   GENERAL MOTORS   Gensler Gary   Gerdeman Fred   Gibson Charles   GLASSDOOR   GLG PARTNERS   GOLDMAN SACHS   Greenspan Alan   Greenspan Glenn   Grey Brad   Griffin Kathy   Griffin Ken   Grove Andy   HALSTON   HARBINGER CAPITAL   PARTNERS   Harrison Gilbert   Harrison Mya   HCR MANORCARE   HEWLETT-PACKARD   HILCO CONSUMER   CAPITAL   Hohman Robert   JEFFRIES & CO.   Jobs Steve   Johnson Magic   Johnson Robert   Jolie Angelina   Jordan Michael   JP MORGAN CHASE   Kaczynski Ted   Karan Donna   Kargman Jill   Karmazin Mel   Kashkari Neel   King Larry   Knowles Beyonce   KohlbergJerry   KopelmanArie   KopelsonAnne   KopelsonArnold   Korff Ira   Korff Kimberlee   Kurzman David   Lagrange Pierre   Lampert Eddie   Lansing Sherry   LEHMAN BROTHERS   LENDINGTREE   Levitt Arthur   Levy Leon   Liddy Ed   LINKEDIN   Little Edward   Loeb Allan   Lois George   LONG-TERM CAPITAL   MANAGEMENT   Lonski John   Lundgren Terry   MACYS   Madoff Bernie   Marcus Bernie   Marriott Bill   Maskin Eric   Mason Richard   MATTHEW WILLIAMSON   MAY DEPARTMENT   STORES   McCombs Red   McKinnon Mark   McLucas William   Meltzer Allan   MERRILL LYNCH   MGM   MICROSOFT   MIDWAY GAMES   Misner Jeff   Mitchell Andrea   Moglia Joe   Molinaro Sam   MOODYS INVESTORS   SERVICE   Moonves Leslie   Morgan Peter   MORGAN STANLEY   Moses Herb   MOTOROLA   Mozilo Angelo   Murdoch Rupert   Murphy Eddie   MYSPACE   Nader Ralph   Nardelli Bob   NATIONAL AMUSEMENTS   NEWS CORP.   Nicholas Pete   Nicklaus Tack   NICKLAUS DESIGN   NIKE   Norquist Grover   NRDC EQUITY PARTNERS   Obama Barack   ODYSSEY PARTNERS   Oman Brady   OPPENHEIMER & CO.   OReilly Bill   OReilly Tim   OVERTURE FILMS   Paese Michael   Palin Sarah   PALM   Pandit Vikram   PARAMOUNT PICTURES   Partnoy Frank   Pataki George   Paulson Henry   Paulson John   Preston Kelly   Purcell Philip   Pyle Jason   RBS GREENWICH CAPITAL   Reardon Roy   Redstone Brent   Redstone Eddie   Redstone Michael   Redstone Paula   Redstone Phyllis   Redstone Shari   Redstone Sumner   RELIANCE   RENAISSANCE TECHNOLOGIES   ROYAL DUTCH SHELL   Rubin Robert   SAC CAPITAL ADVISORS   SALTON   SAPPHIRE ENERGY   Schiff Stephen   Schrager Ian   Schumer Chuck   Schwartz Alan   Scott Lee   Shields Brooke   SHUTTERFLY   SIEMENS   Silverman Ben   Simons James   SIX APART   SOCIALIZR   SOLAZYME   Sorkin Aaron   Sorkin Andrew Ross   Soros George   Spielberg Steven   Spurlock Morgan   Stallone Sylvester   Stanley Stephen   Staubach Roger   Steel Robert   Steinberg Mark   Stern Andy   Stiglitz Joseph   ST. MARTINS PRESS   Stone Oliver   Sullivan Mark T.   Summers Lawrence   SUTTER HILL VENTURES   TACONIC CAPITAL PARTNERS   DESIGN TOMMY HILFIGER   Travolta John   Trump Ivanka   TSM CAPITAL   CENTURY FOX   AFRIKA   TYCO   UBS   UNITED ARTISTS   UNIVERSAL   VALENTINO FASHION   GROUP   VANTAGE   V AUSTRALIA   VENROCK ASSOCIATES   VIA COM   Volcker Paul   VONAGE   WACHOVIA   Wagner Paula   Wales Jimmy   Wallison Peter   WAL-MART   WarinJoseph   WARNER BROTHERS   WASHINGTON MUTUAL   Waters Maxine   Waxman Henry   Weinstein Bob   Weinstein Harvey   WEINSTEIN CO.   Weiser Stanley   Welch Jack   Welling Beau   Whitacre Ed   White Kevin   Whitehead John   Williams Brian   Wilson Victoria   WMS INDUSTRIES   Wolfson Jonathan   


Copyright © 2009 StockRing.com. All rights reserved.
Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.

Buy from S&P 500:
Akamai - AKAM
Amazon.com - AMZN
Big Lots - BIG


Sell from S&P 500:
Alcoa - AA
Autodesk - ADSK
Aflac - AFL


Buy from S&P 400 MidCap:
Carmax - KMX
99c Stores - NDN
Netflix - NFLX


Sell from S&P 400 MidCap:
Timken - TKR
Trinity - TRN
Aflac - AFL


Buy from S&P 600 SmallCap:
Coinstar - CSTR
Holly - HOC
Maximus - MMS


Sell from S&P 600 SmallCap:
Barnes - B
Cascade - CAE
Brightpoint - CELL


Buy from Nasdaq 100:
Baidu.com - BIDU
Verisign - VRSN
Yahoo - YHOO


Sell from Nasdaq 100:
Adobe - ADBE
Amgen - AMGN
Costco - COST


Buy from Nasdaq Telecom:
Adtran - ADTN
CalAmp - CAMP
KongZhong - KONG


Sell from Nasdaq Telecom:
iBasis - IBAS
Interphase - INPH
RCN Corp - RCNI


Buy from Nasdaq Biotech:
Eurand - EURX
Illumina - ILMN
Trimeris - TRMS


Sell from Nasdaq Biotech:
Antigenics - AGEN
Celera - CRA
Incyte - INCY


Buy from Nasdaq Computer:
eLoyalty - ELOY
LogicVision - LGVN
Macrovision - MVSN


Sell from Nasdaq Computer:
Amtech - ASYS
Bsquare - BSQR
Corel - CREL


Buy from Nasdaq Finance:
Elbit - EMITF
Chardan - CACA
Tree.com - TREE


Sell from Nasdaq Finance:
BancFirst - BANF
FirstMerit - FMER
Advanta - ADVNA

No comments:

Post a Comment

Followers

Blog Archive

About Me

My photo
My name is Eric Katsov and I work at StockRing.com. This blog is to reflect the latest developments that we observe on the stock market from StockRing point of view. StockRing developed unique risk evaluation technology that allows to minimize losses for large diversified portfolios of stocks and mutual funds via weekly portfolio monitoring. StockRing clients receive Weekly Status Reports with Buy-Sell-Hold ratings assigned to all their stocks and mutual funds. StockRing serves a lot of 401k and 403b clients who are limited to investing into just a few of mutual funds and StockRing sends Weekly 401K Status Reports to help clients to chose the best funds to invest in.